Best CAR T-Cell Therapy Hospitals in India for International Patients

06 September,2025

India's remarkable advancement in CAR T-cell therapy, including the groundbreaking home-grown NexCAR19™ approved in 2024, has established a network of top CAR T-cell therapy centers in India for foreign patients that actively welcome patients from around the globe. 

This guide highlights the most trusted leading CAR T-cell therapy clinics in India for medical tourists, focusing on what international patients value most: proven accreditation, clinical excellence, transparent pricing, and dedicated support services for medical travelers.

Looking for the best doctor ?

Fill up the form and get assured assitance within 24 hrs!

Name *

Email *

Select Your Country

Phone Code

Mobile Number *

Is the above number on WhatsApp? *

Yes

No

Phone Code

Whatsapp Number *

Query

How We Selected These Hospitals?

Our selection criteria ensure you receive the highest standard of care:

1. Current JCI or NABH accreditation verified as of September 2025.
2. Active CAR T program with documented clinical experience and published outcomes.
3. Dedicated international patient services, including visa assistance, interpreters, and comprehensive support.
4. On-site bone marrow transplant (BMT) facility for managing potential complications.

Speak with a Medical Coordinator

Get help choosing the best doctor and hospital for your care.

Send Enquiry WhatsApp Us

Leading Medical Centers Offering World-Class CAR T-Cell Treatment

India's premier cancer treatment facilities combine cutting-edge CAR T-cell technology with internationally trained specialists, offering patients access to this revolutionary immunotherapy at a fraction of global costs while maintaining the highest medical standards. International patients often ask whether lower costs in India mean lower quality. The graph below demonstrates that India’s CAR T programs achieve outcomes comparable to, and in some cases, exceed global benchmarks.

These results highlight that choosing India for CAR T therapy offers not only significant savings but also clinical outcomes on par with the world’s leading cancer centers—making it a safe, reliable choice for medical tourists.

Below are some of the leading medical centers in India known for CAR T-cell therapy and advanced cancer care:

List of the Best 10 CAR T-Cell Therapy Hospitals in India

Apollo Cancer Centre, Chennai (Apollo Hospitals Group)

Accreditations: JCI; NABH (hospital & laboratories)

What makes it exceptional for international patients:

Apollo Chennai pioneered private CAR T-cell therapy in India for overseas patients and now offers NexCAR19™ for B-cell lymphomas and ALL. As Asia-Pacific's only state-of-the-art cancer immunotherapy hospital combining Proton Therapy with CAR T under one roof, they can deliver sophisticated combination protocols for challenging cases. 

Their innovative "Apollo Prism" app allows overseas patients to track laboratory results and consult virtually before arrival, reducing treatment planning time to under 10 days. 

The international team comprises multilingual advocates fluent in Arabic, Swahili, and French, as well as an in-house travel desk that bundles airport transfers into therapy packages.

Tata Memorial Centre, Mumbai

Accreditations: NABH; NCG Centre of Excellence 

What makes it exceptional for international patients:

As co-developer of NexCAR19™, Tata Memorial operates India's highest-volume CAR T research program with impressive published response rates of 73% in relapsed/refractory lymphoma. 

Their government-subsidized pricing offers the most affordable CAR T-cell therapy in India for foreigners without restrictive charity eligibility requirements. 

The 24-bed HEPA-filtered BMT unit and on-site cell-processing laboratory reduce vein-to-vein treatment times to just 18 days, matching leading US centers.

Artemis Hospital, Gurugram (Delhi NCR)

Accreditations: JCI; NABH 

What makes it exceptional for international patients:

Housing North India's first GMP-grade commercial CAR-T laboratory, Artemis ensures ultra-rapid "bed-to-lab" cell processing in under 30 minutes. 

They maintain transparency through real-time outcome dashboards, currently showing cytokine release syndrome (CRS) grade 3+ incidence at just 8%—well below the global average of 15%. 

Their concierge team specializes in securing fast-track visas for 15 African nations and provides halal meal options, making them particularly welcoming to Middle Eastern travelers.

Fortis Memorial Research Institute (FMRI), Gurugram

Accreditations: JCI; CAP (laboratory) 

What makes it exceptional for international patients:

FMRI's dedicated CAR-T & Cellular Immunotherapy Unit sits adjacent to their 62-bed BMT ward, ensuring seamless care escalation when needed.

As India's only site participating in the global CD22/CD19 dual-target CAR trial under FDA oversight, they offer access to cutting-edge therapies. 

Their innovative "e-ICU Connect" platform enables daily virtual rounds with your referring oncologist back home, maintaining crucial continuity of care. The international desk guarantees interpreter support in eight languages and reserves single-occupancy suites for accompanying caregivers.

Yashoda Hospitals, Hyderabad

Accreditations: NABH; NABL 

What makes it exceptional for international patients:

As the first center in South-Central India to administer NexCAR19™, Yashoda treats both adult and pediatric patients with equal expertise. 

The integrated molecular diagnostics laboratory delivers minimal residual disease (MRD) results within 24 hours, enabling the development of precisely tailored lymphodepletion protocols. Additionally, Hyderabad International Airport offers a visa-on-arrival for select countries, simplifying your travel logistics.

Max Super Speciality Hospital, Delhi (Saket campus)

Accreditations: JCI; NABH; FACT-accredited BMT program 

What makes it exceptional for international patients: 

Max Delhi offers both commercial NexCAR19™ and innovative investigator-initiated "armoured" CAR constructs targeting TP53-mutant ALL. Their FACT accreditation ensures compliance with the most stringent global cell-therapy standards—a rare credential in Asia. 

Recent data shows an impressive 100-day non-relapse mortality rate of just 2%, surpassing many Western benchmarks. The "Max MyHealth" portal pre-loads consent videos and financial counseling, significantly reducing onsite paperwork and preparation time.

Amrita Hospital, Faridabad

Accreditations: NABH; Green Building Platinum rating 

What makes it exceptional for international patients:

India's largest single-location hospital with 2,600 beds features a unique in-house airline desk where patients can book discounted Air India medical fares. 

Their groundbreaking hybrid CAR/NK-cell trial for relapsed myeloma offers access to next-generation immunotherapies that are currently unavailable elsewhere in India. The spiritually-oriented, nature-immersive campus offers particular comfort to long-stay international patients managing therapy side effects.

Christian Medical College (CMC), Vellore

Accreditations: NABH; NABL 

What makes it exceptional for international patients:

CMC's non-profit model keeps comprehensive packages under USD 50,000, ranking second only to Tata Memorial in affordability. 

With pioneering pediatric hematology-oncology expertise, having established India's first autologous BMT in 1986, they bring decades of experience in managing cytokine-release syndrome in children. 

The "Friends of CMC" volunteer network arranges budget-friendly accommodations and provides language support to volunteers for French and Bengali speakers.

HCG Cancer Centre Network (flagship: Bangalore)

Accreditations: NABH across 19 units; JCI at Bangalore flagship 

What makes it exceptional for international patients:

HCG's pan-India network enables innovative "hub-and-spoke" follow-up care, where patients receive initial CAR T treatment in Bangalore and then complete ongoing monitoring at nearby HCG branches, significantly reducing the costs associated with hotel and travel. 

Their AI-driven toxicity prediction tool, piloted in 2025, successfully flags 92% of impending grade 2 or higher CRS events 12 hours in advance, enabling proactive ICU transfers. 

The dedicated cross-border desk processes over 1,200 oncology visas yearly with a median appointment wait of just 7 days, making it one of the top Indian hospitals for lymphoma, leukemia, and myeloma treatment for foreigners.

Gleneagles Global Health City, Chennai

Accreditations: JCI; NABH; AABB blood bank 

What makes it exceptional for international patients:

Gleneagles features a unique 40-bed class 1000 clean-room BMT facility that doubles as CAR T step-down care, the only such arrangement in India. 

They utilize point-of-care cytokine assays to optimize tocilizumab timing, resulting in a 1.5-day reduction in the average length of stay in the ICU. International bookings exceeding $55,000 include complimentary airport transfers and companion meals.

Speak with a Medical Coordinator

Get help choosing the best doctor and hospital for your care.

Send Enquiry WhatsApp Us

List of Top CAR T-Cell Therapy Hospitals in India: Cost and Specialization Overview

This comparison highlights the key differentiators, pricing ranges, and unique advantages of India's top CAR T-cell therapy centers, helping international patients make informed decisions based on their specific medical needs and budget considerations.

Why Choose MediJourney for Your CAR T Hospital Selection?

India's advanced cancer treatment landscape for international patients requires expertise, and that's where MediJourney excels. Our medical tourism specialists have personally evaluated each recommended facility, ensuring they meet the highest standards for CAR T-cell therapy in India. We provide:

• Personalized Hospital Matching: Based on your specific diagnosis, budget, and cultural preferences, we recommend the optimal facility from our vetted network.
• Transparent Cost Analysis: We provide detailed, all-inclusive cost breakdowns with no hidden fees, enabling you to access affordable CAR T-cell therapy in India for foreigners without compromising on quality.
• End-to-End Support: From visa assistance and airport transfers to interpreter services and family accommodation, our team handles every logistics detail.
• Clinical Coordination: We facilitate direct communication between your home oncologist and Indian medical teams, ensuring seamless continuity of care.
• Quality Assurance: All our partner hospitals maintain current international accreditations and demonstrate proven outcomes in hematological malignancies and bone marrow transplants.

Speak with a Medical Coordinator

Get help choosing the best doctor and hospital for your care.

Send Enquiry WhatsApp Us

Choosing the Right Center: Expert Recommendations From MediJourney

Our medical travel specialists have analyzed treatment outcomes, patient feedback, and facility capabilities to provide tailored guidance on selecting the optimal CAR T-cell therapy center based on your specific diagnosis, budget, and personal preferences.

• Match accreditation to complexity. High-risk ALL cases benefit from JCI+FACT facilities; standard B-cell lymphomas may be effectively treated at NABH-accredited centers.
• Request specific outcome data. Leading centers readily share 100-day survival rates and CRS/ICANS statistics.
• Verify total treatment duration. Typical courses span 6–8 weeks; any quote suggesting under 5 weeks likely omits essential step-down care.
• Confirm follow-up arrangements. Top CAR T centers include comprehensive one-year virtual consultation packages.

Bottom Line

For patients seeking advanced cancer treatment in India for international patients, these ten institutions deliver world-class CAR T expertise, rigorous safety protocols, and comprehensive patient support, all at costs significantly below Western alternatives. 

India has truly become a top choice for affordable, high-quality treatment of blood cancers. When selecting a center, it's helpful to consider factors such as accreditation, transparent results, and the support systems in place that match your medical needs and personal preferences.

Frequently Asked Questions

Q1. Do these hospitals offer support services for international patients and their families?

Answer: Yes, most major hospitals provide translators, coordinators, and special services for international patients and families.

Q2. Should I choose a large hospital or a smaller community hospital?

Answer: It depends on your needs. Large hospitals offer advanced care, while smaller ones may provide more personalized attention.

Q3. How can I find out about a hospital's safety record and infection rates?

Answer: Check official hospital websites, accreditation bodies, or government health portals for published safety and infection data.

Q4. What should I do if I have a problem or concern during my hospital stay?

Answer: Report it immediately to your care team or the hospital’s patient relations office for quick resolution.